Filing Details

Accession Number:
0001437749-24-008707
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-20 16:38:32
Reporting Period:
2024-03-18
Accepted Time:
2024-03-20 16:38:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1668243 Urogen Pharma Ltd. URGN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763581 Mark Schoenberg 400 Alexander Park Drive
Princeton NJ 08540
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2024-03-18 12,000 $14.05 139,437 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. A portion of the cash receipts will be used for federal income tax purposes